期刊文献+

2′-C-甲基尿苷的合成工艺改进

Improved synthetic process of 2′-C-methyluridine
原文传递
导出
摘要 目的研究2′-C-甲基尿苷的新合成方法。方法以1-O-乙酰基-2,3,5-三-O-苯甲酰基-β-D-呋喃核糖(2)为原料,经酸性水解、Swern氧化、格氏反应、苯甲酰化、缩合、酯水解6步反应得到2′-C-甲基尿苷。结果与结论2′-C-甲基尿苷及部分中间体的结构经MS、^1H-NMR谱确证,6步反应总收率为27.0%(以2计),产品纯度99.0%(HPLC面积归一化法),该合成路线具有原料易得、路线较短、安全性高、操作简便等特点。 An improved synthetic process of 2′-C-methyluridine was reported.2′-C-methyluridine was synthesized via acid-catalyzed hydrolysis,Swern oxidation,Grignard reaction,benzoylation,condensation and alkalinity hydrolysis using 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranoside(2)as starting material.The total yield of 2′-C-methyluridine was up to 27.0%(based on compound 2)and the HPLC purity was 99.0%.The structure of the title product was confirmed by MS(ESI)and^1H-NMR.The improved process has many advantages,such as inexpensive materials,low cost,milder reaction conditions,higher yield,and it′s more suitable for industrial production.
作者 杨俊 户晖 马立荣 刘子越 赵建宏 YANG Jun;HU Hui;MA Li-rong;LIU Zi-yue;ZHAO Jian-hong(School of Pharmacy,East China University of Science and Technology,Shanghai 200237,China)
出处 《中国药物化学杂志》 CAS CSCD 北大核心 2019年第5期374-376,381,共4页 Chinese Journal of Medicinal Chemistry
关键词 1-O-乙酰基-2 3 5-三-O-苯甲酰基-β-D-呋喃核糖 2′-C-甲基尿苷 工艺改进 1-O-acetyl-2,3,5-tri-O-benzoyl-β-D-ribofuranoside 2’-C-methyluridine process improvement
  • 相关文献

参考文献1

二级参考文献6

  • 1US FDA.FDA approval of Sovaldi(sofosbuvir)tablets for the treatment of chronic hepatitis[EB/OL].[2013-12-06].http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/ucm377920.htm.
  • 2AXT S D,SARMA K,VITALE J,et al.Preparation of nucleosides ribofuranosyl pyrimidines:WO,2008045419[P].2008-04-17.
  • 3ROSS B S,REDDY P G,ZHANG H R,et al.Synthesis of diastereomerically pure nucleotide phosphoramidates[J].J Org Chem,2011,76(20):8311-8319.
  • 4MURAKAMI E,TOLSTYKH T,BAO H,et al.Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977[J].J Biol Chem,2010,285(45):34337-34347.
  • 5JACOBSON I M,GORDON S C,KOWDLEY K V,et al.Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options[J].N Engl J Med,2013,368(20):1867-1877.
  • 6LAWITZ E,MANGIA A,WYLES D,et al.Sofosbuvir for previously untreated chronic hepatitis C infection[J].N Engl J Med,2013,368(20):1878-1887.

共引文献1

  • 1杜月,刘晓平.Epclusa[J].中国药物化学杂志,2017,27(1):87-87.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部